Shi Y - Search Results

1

Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.

Jiang H, Cannella R, Wu Z, Beaufrère A, Dioguardi Burgio M, Sartoris R, Wang Y, Qin Y, Chen J, Chen Y, Chen W, Shi Y, Song B, Ronot M. Jiang H, et al. Among authors: shi y. Radiology. 2024 Nov;313(2):e233471. doi: 10.1148/radiol.233471. Radiology. 2024. PMID: 39499179

2

VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.

Jiang H, Wei H, Yang T, Qin Y, Wu Y, Chen W, Shi Y, Ronot M, Bashir MR, Song B. Jiang H, et al. Among authors: shi y. Radiology. 2023 Apr;307(2):e221835. doi: 10.1148/radiol.221835. Epub 2023 Feb 14. Radiology. 2023. PMID: 36786702

3

Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.

Chen J, Wu Z, Xia C, Jiang H, Liu X, Duan T, Cao L, Ye Z, Zhang Z, Ma L, Song B, Shi Y. Chen J, et al. Among authors: shi y. Eur Radiol. 2020 Feb;30(2):1232-1242. doi: 10.1007/s00330-019-06414-2. Epub 2019 Sep 16. Eur Radiol. 2020. PMID: 31529254

4

Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.

Zhang J, Wu Z, Zhao J, Liu S, Zhang X, Yuan F, Shi Y, Song B. Zhang J, et al. Among authors: shi y. Eur Radiol. 2021 Jun;31(6):3661-3672. doi: 10.1007/s00330-020-07524-y. Epub 2020 Nov 27. Eur Radiol. 2021. PMID: 33245493

5

Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.

Chen J, Xia C, Duan T, Cao L, Jiang H, Liu X, Zhang Z, Ye Z, Wu Z, Gao R, Shi Y, Song B. Chen J, et al. Among authors: shi y. Eur Radiol. 2021 Oct;31(10):7696-7704. doi: 10.1007/s00330-021-07898-7. Epub 2021 Apr 15. Eur Radiol. 2021. PMID: 33856520

6

Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.

Che F, Xu Q, Li Q, Huang ZX, Yang CW, Wang LY, Wei Y, Shi YJ, Song B. Che F, et al. Among authors: shi yj. World J Gastroenterol. 2022 Apr 14;28(14):1479-1493. doi: 10.3748/wjg.v28.i14.1479. World J Gastroenterol. 2022. PMID: 35582676 Free PMC article.

7

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients.

Yuan J, Liu Z, Wu Z, Yan L, Yang J, Shi Y. Yuan J, et al. Among authors: shi y. Front Immunol. 2022 Oct 7;13:990571. doi: 10.3389/fimmu.2022.990571. eCollection 2022. Front Immunol. 2022. PMID: 36275751 Free PMC article.

8

Machine learning: an approach to preoperatively predict PD-1/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers.

Zhang J, Wu Z, Zhang X, Liu S, Zhao J, Yuan F, Shi Y, Song B. Zhang J, et al. Among authors: shi y. ESMO Open. 2020 Nov;5(6):e000910. doi: 10.1136/esmoopen-2020-000910. ESMO Open. 2020. PMID: 33239315 Free PMC article.

9

Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy.

Shao M, Tao Q, Xu Y, Xu Q, Shu Y, Chen Y, Shen J, Zhou Y, Wu Z, Chen M, Yang J, Shi Y, Wen T, Bu H. Shao M, et al. Among authors: shi y. Chin Med J (Engl). 2023 Sep 5;136(17):2066-2076. doi: 10.1097/CM9.0000000000002380. Chin Med J (Engl). 2023. PMID: 37249521 Free PMC article.

10

Relationship Between Histone Deacetylase 3 (HDAC3) and Breast Cancer.

Cui Z, Xie M, Wu Z, Shi Y. Cui Z, et al. Among authors: shi y. Med Sci Monit. 2018 Apr 22;24:2456-2464. doi: 10.12659/msm.906576. Med Sci Monit. 2018. PMID: 29680858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,442 results

Search Page

Filters